Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.41 |
| ▸ | EGLN1 | Q9GZT9 | 4/20 | 0.41 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.41 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.41 |
| ▸ | KDM2A | Q9Y2K7 | 5/20 | 0.40 |
| ▸ | KDM5C | P41229 | 3/20 | 0.40 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.40 |
| ▸ | KDM6B | O15054 | 2/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.33 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.33 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15270647 | 0.81 | LMNA (0.45) | LMNAEGLN1ALKBH5SUCNR1KDM2A | |
| SCHEMBL8528906 | 0.80 | TSHR (0.56) | LMNATSHRKDM4EALDH1A1 | |
| SCHEMBL14661595 | 0.77 | EGLN1 (0.45) | LMNAEGLN1ALKBH5SUCNR1KDM2A | |
| SCHEMBL733970 | 0.77 | ALDH1A1 (0.48) | LMNAMAPK1TSHRALDH1A1 | |
| SCHEMBL9095817 | 0.74 | LMNA (0.52) | LMNAMAPK1TSHRALDH1A1 | |
| SCHEMBL15270649 | 0.74 | LMNA (0.36) | LMNAEGLN1ALKBH5SUCNR1KDM2A | |
| SCHEMBL2171703 | 0.73 | TSHR (0.32) | TSHR | |
| SCHEMBL8154447 | 0.72 | LMNA (0.60) | LMNAMAPK1TSHRALDH1A1 | |
| SCHEMBL29637404 | 0.72 | EGLN1 (0.41) | LMNAEGLN1ALKBH5SUCNR1KDM2A | |
| SCHEMBL2063826 | 0.71 | TRPA1 (0.37) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1285747-A | Combination therapy for the treatment of AIDS | MERCK & CO INC (US) | 2001-02-28 | — | — | CN | disclosed |
| US-5733907-A | Prodrugs of an inhibitor of HIV protease | MERCK & CO., INC. (US) | 1998-03-31 | — | — | US | disclosed |
| EP-0806957-A1 | COMBINATION THERAPY FOR HIV INFECTION USING THE HIV PROTEASE INHIBITOR INDINAVIR ADN THE REVERSE TRANSCRIPTASE INHIBITOR 3TC, OPTIONALLY TOGETHER WITH AZT, DDI OR DDC | Merck & Co., Inc. (US) | 1997-11-19 | — | — | EP | disclosed |
| EP-0767664-A2 | COMBINATION THERAPY FOR HIV INFECTION | MERCK & CO. INC. (US) | 1997-04-16 | — | — | EP | disclosed |
| EP-0729467-A1 | PRODRUGS OF AN INHIBITOR OF HIV PROTEASE | MERCK & CO. INC. (US) | 1996-09-04 | — | — | EP | disclosed |
| WO-1996023509-A1 | COMBINATION THERAPY FOR HIV INFECTION USING THE HIV PROTEASE INHIBITOR INDINAVIR AND THE REVERSE TRANSCRIPTASE INHIBITOR 3TC, OPTIONALLY TOGETHER WITH AZT, DDI OR DDC | MERCK & CO., INC. (US) | 1996-08-08 | — | — | WO | disclosed |
| WO-1996000068-A2 | COMBINATION THERAPY FOR HIV INFECTION | MERCK & CO., INC. (US) | 1996-01-04 | — | — | WO | disclosed |
| WO-1995014016-A1 | PRODRUGS OF AN INHIBITOR OF HIV PROTEASE | MERCK & CO., INC. (US) | 1995-05-26 | — | — | WO | disclosed |